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Abstract 
Purpose: The accurate prediction of stray neutron dose has become increasingly important as it 
increases the risk of second cancer development after proton therapy. Previously reported analyt-
ical models predicted the quantity dose equivalent, which includes physical and biological con-
siderations but does not explicitly take into account material dependence and variation in the ra-
diation quality. The purpose of this study was to investigate the feasibility of an analytical model 
of absorbed dose to water from stray neutrons in proton therapy.  
Methods: To calculate neutron absorbed dose and kerma in water, the authors developed analyti-
cal models of neutron spectral fluence and kerma coefficients, used neutron spectral fluence and 
absorbed dose data from Monte Carlo simulations, and evaluated neutron kerma coefficients 
from the literature.  
Results: The analytical model predictions of absorbed dose to water agreed relatively well with 
that from Monte Carlo simulations. On average, the percentage difference between the analytical 
model and Monte Carlo simulations was 49 percent for absorbed dose to water for the proton 
beam energies ranging from 120 MeV to 250 MeV. 
Conclusion: The results suggest that it is feasible to analytically model absorbed dose to water 
from stray neutrons with good accuracy. A potentially important advantage of this fluence-based 
approach is that it provides the ability to take material dependence into account and helps with 
characterization of radiation quality. 
1 
Chapter 1. Introduction 
Cancer is one of the most significant health issue in the developed world. Approximately 
one in two men and women will be diagnosed with some form of cancer in their lifetime 
(Howlader et al. 2014). With advancements in cancer care the 5-year survival rate is now 83% 
averaged overall for all cancers (Siegel et al. 2018) and the number of cancer survivors in United 
States is expected to increase from 15.5 million in 2016 to 20.3 million by 2026 (DeSantis et al. 
2014, Siegel et al. 2018). Nearly two thirds of all cancer patients will receive radiation therapy at 
some point during their treatment (Smart 2010). 
Radiation-induced late effects, such as cardiac toxicity, second cancers, and fertility com-
plications, are prevalent in these cancer survivors (NRC 2006, NCRP 2011, Williams et al. 
2018). With increasing survival, it has become essential to understand the mechanism behind 
these complications in an attempt to mitigate against them and improve the quality of life for 
cancer survivors. 
Childhood cancer survivors who received radiation therapy are at elevated risk for health 
complications, with a 2.5 times increased risk of developing a second cancer when compared to 
their healthy siblings (Tukenova et al. 2010). Modern radiation therapy techniques, such as pro-
ton therapy, seek to avoid radiation side effects by delivering a highly conformal dose to the tu-
mor. However, normal tissues outside the treatment field are unavoidably exposed to considera-
ble levels of scattered and leakage radiation (Figure 1.1). Most secondary malignancies in adults 
occur outside the primary field (Doerr et al. 2002, Diallo et al. 2009) implicating stray radiation 
exposures. Therefore, accurate prediction of stray dose will become increasingly important for 
understanding and avoiding radiogenic second cancers.  
2 
Figure 1.1. Schematic diagram representing a treatment head and patient treated. Therapeutic ra-
diation beam is shown in red while blue represents stray radiation incident upon patient's whole 
body (Newhauser et al. 2011). 
Proton therapy provides uniform target coverage and lower dose to normal tissue than 
photon therapy. However, patients undergoing proton therapy still receive stray radiation dose, 
primarily from neutrons that are generated in treatment head and the patient’s body (Figure 1.1). 
These neutrons are created through various physical processes such as direct reactions, pre-com-
pound emission, compound emission, etc. Theoretically the risk of secondary cancer after proton 
therapy is significantly lower than that after photon therapy, but epidemiologic evidence is lack-
ing.  
Measurements of the neutron fields generated during proton therapy have provided criti-
cal insights. Yan et al. (2002) measured the neutron dose equivalent outside the treatment field 
and demonstrated the existence of a neutron bath from three proton-therapy beamlines. Since 
then, numerous researchers have reported measurements of secondary neutron dose for a proton-
3 
therapy beamline, which were selectively reviewed in NCRP (2011). Tayama et al. (2006) vali-
dated Monte-Carlo codes using measurements of neutron yield for various proton energies. 
Measurements are essential for developing (Schneider et al. 2015) and validating (Farah et al. 
2015) analytical models of both therapeutic and stray dose. Recently myriad measurement-based 
studies has been published for pencil beam scanning (Islam et al. 2017, Trinkl et al. 2017) as 
well as passive-scattering (Howell et al. 2016, De Smet et al. 2017) proton beamlines. Measure-
ments are technically challenging and time consuming. 
Monte Carlo simulations allow researchers to determine in-field and out-of-field neutron 
dose for arbitrary geometries and treatment modalities. Though extremely insightful, the long 
computation times and complexity of MC simulations has limited its application to research set-
tings. Agosteo et al. (1998) first utilized MC methods to simulate dose from secondary neutrons 
and photons from an ocular proton treatment. In addition to the quantities provided by basic 
measurements, it is possible to determine and discriminate the source of the particles, which can 
be used to develop analytical models. These advantages led to increasing literature of neutron ex-
posure simulated with MC techniques (Newhauser et al. 2002, Hongyu et al. 2005, Zheng et al. 
2008, Perez-Andujar et al. 2013, Zhang et al. 2013). This approach has been applied to both ac-
tive scanning (Trinkl et al. 2017) and passive (Farah et al. 2015, Bonfrate et al. 2016) beamlines. 
Data generated by MC are being used for the training and validation of analytical models. 
To develop methods suitable for routine clinical calculations of absorbed dose, several 
research groups have proposed analytical models. An early attempt to analytically model neutron 
dose was reported by Polf et al. (2005). Anferov (2010) proposed an analytical model for con-
verting proton beam losses into secondary-neutron dose. Newhauser et al. (2017) presented a 
concise review of recent analytical models and their efficacy and concluded that these may offer 
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faster computations of equivalent dose with acceptable accuracy. Another such model has been 
developed by Newhauser and co-workers over the past decade. It is nonproprietary and straight-
forward to implement. Basic versions of these analytical models were developed between 2006 
and 2010 at The University of Texas MD Anderson Cancer Center (Zhang et al. 2010) and ad-
vanced versions between 2011 and 2017 at Louisiana State University with collaborators from 
Mary Bird Perkins Cancer Center and other institutions (Perez-Andujar et al. 2013, Eley et al. 
2015, Farah et al. 2015, Schneider et al. 2015). This model estimates equivalent dose per pre-
scribed proton absorbed dose in water phantom. The recent version reported by Schneider et al. 
(2015) was simpler to configure and use than previously version and offered continuous applica-
bility from 100-250 MeV in proton beam energy. Eley et al. (2015) integrated this model into a 
treatment planning system and extended the model to include range modulation and arbitrary 
collimator shapes. Gallagher et al. (2018) performed an independent application and evaluation 
of this model in clinically realistic circumstances and demonstrated that analytical models may 
be useful for clinicians and researchers to calculate equivalent dose. As explained, previous mod-
els have predicted the quantity dose equivalent, which was developed for radiation protection 
purposes and includes an amalgamation of physical and biological considerations. However, this 
approach is limited in that it does not take into account material dependence (e.g., muscle versus 
bone) and does not allow characterization of radiation quality.  
The objective of this study was to investigate the feasibility of an analytical model of ab-
sorbed dose to water from stray neutrons in proton therapy. The model calculates neutron spec-
tral fluence, kerma coefficients, kerma, absorbed dose, and mean neutron energy. 
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Chapter 2. Methods and Materials 
2.1 Kerma and Absorbed Dose 
The interactions of neutrons in matter depends upon their energy and material composi-
tion. Low energy neutrons in tissue mostly undergo neutron capture by nitrogen or hydrogen 
whereas intermediate and fast neutrons mostly interact through elastic scattering on hydrogen nu-
clei. Very fast neutrons can undergo non-elastic nuclear reactions with a nucleus or one or more 
nucleons in a nucleus. 
The kerma (𝐾) for neutrons is given by 




where d𝜖𝑡𝑟 is the mean sum of the initial kinetic energy of all the charged particles liberated in 
the mass d𝑚 of a material by the neutrons incident on d𝑚.  
Due to radiative losses and escaping charged particles, not all of the energy is deposited 
locally, i.e., at the incident neutron’s original point of interaction. The absorbed dose (𝐷) is 
given by 




where d𝜖 is the expectation value of energy imparted to matter of mass d𝑚. 
Kerma and absorbed dose are related. The value of the kerma approaches that of the ab-
sorbed dose to the degree that charged particle equilibrium (CPE) exists, that radiative losses are 
negligible. CPE exists at a point if charged-particle fluence rate, differential in energy and direc-
tion, is constant within distances equal to the maximum charged-particle range (ICRU 2000, 
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ICRU 2014). Under conditions of CPE each charged particle of a given type and energy leaving 




 𝜖 (3) 




In polyenergetic fields kerma is, 





where Φ(𝐸n) is the neutron spectral fluence, 𝑘ϕ(𝐸n) is kerma coefficient and 𝐸n is neutron en-
ergy. Thus, substituting Equation (4) in Equation (5), we have  
𝐷 =
CPE





This expression is very useful because with knowledge of the neutron spectral fluence and kerma 
coefficients, we can calculate kerma and, under condition of CPE, the absorbed dose. 
2.2 Model for Kerma Coefficient 
The kerma coefficient, 𝑘ϕ(𝐸n), or fluence-to-kerma conversion coefficient, is the quo-
tient of the kerma at a given point in a material by the fluence of uncharged ionizing particles, Φ, 






The kerma coefficient may also be calculated from the microscopic cross sections accord-
ing to 






where 𝑁j denotes the number of target nuclides of type j per unit mass in the material, 𝜖i̅j the av-
erage energy transferred to kinetic energy of charged particles of type i, and 𝜎ij
prod(𝐸n) the total
production cross section for a charged particle of type i.  
Neutron kerma coefficients are well known below 20 MeV and, with larger uncertainties, 
between 20 MeV and 150 MeV. At higher neutron energies, information on microscopic cross 
sections and evaluated kerma coefficient is uncertain and incomplete (ICRU 2000).  
2.2.1 Analytical Model of Neutron Kerma Coefficient 
In this study we propose the following piecewise formula for neutron kerma coefficients 









+ 𝛨(𝐸n − 𝐸n,Thresh)   (𝑢 𝐸n
2 + 𝑣)
(9) 
where H is the Heaviside function, 𝐸n  is neutron energy, and  𝐸n,Thresh is the neutron threshold 
energy that determines the energy interval covered by each of the two higher energy terms. 
𝑎1, 𝑏1, 𝜎1
′, 𝜇1, 𝑢 and 𝑣 are empirical parameters whose values are obtained by fitting Equation
(9) to tabulated kerma coefficient data. Equation (9) uses a hyperbolic cosine function for ther-
mal regions, log-normal distribution below 𝐸n,Thresh and second order polynomial to model 
kerma coefficient at higher energies. 
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2.2.2 Kerma Coefficient Data for Fitting 
We fitted Equation (9) to evaluated kerma coefficient data from ICRU (2000) (ICRU Re-
port 63). The models and experimental data used to derive the evaluated data tables were de-
scribed by the ICRU (2000). We fitted kerma coefficient data for water, bone, air, muscle, TE-
Methane, TE-Propane, A150 tissue substitute plastic, over the interval of 2.53 × 10−8 MeV to
150 MeV neutron energy. 
2.2.2 Fitting Procedure 
Fitting was performed using a non-linear least squares method and trust-region algorithm 
implemented in commercial software (MATLAB® and Curve Fitting Toolbox 3.5.6, 2017b, The 
MathWorks Inc., Natick, Massachusetts, United States). To assess goodness of fit, average and 
maximum differences between analytical model and evaluated kerma coefficient data were re-
ported. 
2.3 Analytical Model for Neutron Spectral Fluence 
2.3.1 Analytical Model 
Neutrons emitted during proton therapy span about twelve decades of energy. Following 
the approach from our group (Perez-Andujar et al. 2013, Schneider et al. 2015), we subdivided 
the spectra into four neutron energy regimes (intranuclear cascade, evaporation, 1 𝐸n
⁄  and ther-
mal), as shown in Figure 2.1.  
A fast proton may penetrate the coulomb barrier of an atomic nucleus. Once inside, it 
may interact directly with one or a few nucleons, resulting in their emission, usually in the cone 
of the forward direction due to the principle of conservation of energy. These are called cascade 
neutrons or direct neutrons. The incident proton may interact with many nucleons in the nucleus, 
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thus sharing the kinetic energy amongst them. As this process of sharing proceeds, the energy is 
statistically distributed, eventually reaching an equilibrium where the nucleus is in an excited 
state. After equilibration, the compound nucleus comprises the original nucleus and the incident 
proton. The nucleus can de-excite by evaporating off one or more of its nucleons, in a manner 
that is analogous to the evaporation of water, which is sometimes called compound emission. 
Nucleons may be emitted during the equilibration process, which is called pre-equilibrium emis-
sion. The third energy regime, 1 𝐸n
⁄  neutrons, correspond to neutrons that have lost some portion
of their energy via inelastic scattering, a process referred to as moderation. A small proportion of 
these neutrons will be lost via capture processes. Finally, the lowest energy regime corresponds 
to moderated neutrons that have lost most of their kinetic energy and are in thermal equilibrium 
with the environment. These undergo elastic scattering until they are eventually captured, e.g. by 
hydrogen and nitrogen nuclei in the material. The emission of evaporation neutrons, 1 𝐸n
⁄  neu-
trons and thermal neutrons is isotropic in nature due to loss of directionality information during 
the equilibration process. 
The analytical model for neutron spectral fluence at any point 𝑝(𝑥, 𝑦, 𝑧) in a water phan-
tom is given by 




where  𝐹𝐸p  is proton energy scaling factor that characterizes the dependence of magnitude of
neutron fluence on proton beam energy and is given by, 
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 where 𝛼E is a constant and 𝜉 is an exponent governing the power law dependence in proton en-
ergy, 𝐸p is proton energy and, 𝐸p,ref is a reference proton energy. Both 𝛼E and 𝜉 are empirical fit 
parameters. In this work, 𝐸p,ref was 120 MeV. In this work, spectral fluence and fluence are nor-
malized per proton entering the treatment head. 






Figure 2.1. Neutron energy fluence spectrum from proton therapy illustrating contributions from 
separate energy regimes. 
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where 𝑑 is distance from the effective neutron source to calculation point 𝑝(𝑥, 𝑦, 𝑧) (Figure 2.2), 
𝑑iso is the distance from the effective neutron source to isocenter (Figure 2.2), and the exponent 
𝜏 governs the rate of divergence of the source.  
The effective attenuation factor (𝐴𝐹i) of neutrons in water is given by 
𝐴𝐹i =  𝑒
−𝛼i[𝑑
′−𝑑iso
′ ] (13) 
where 𝛼i is the effective attenuation coefficients for the 𝑖
th neutron energy regime, 𝑑iso
′  is the
distance from phantom surface to the isocenter (Figure 2.2), and 𝑑′ is the distance from the sur-
face to the calculation point along the ray (Figure 2.2).  
The off-axis factor (𝑂𝐴𝐹i) describes the lateral distribution of neutron fluence and is 













where, 𝜎i is the gaussian width parameter of the 𝑖
th neutron energy regime. The gaussian width
parameter after variable transformation in Equation (14), (
𝜎i𝑧
𝑑iso
) scales with depth 𝑧 to take into
account geometric magnification. 
Finally, ϕi(𝐸n), represents the contribution of spectral fluence to a point in the phantom 
from 𝑖th neutron regime, where ϕ1(𝐸n) denotes the contribution from thermal neutrons, ϕ2(𝐸n)
denotes the contribution from 1 𝐸n
⁄  neutrons, ϕ3(𝐸n) denotes the contribution from evaporation
neutrons, and ϕ4(𝐸n) denotes the contributions from high-energy neutrons. 
Thermal neutrons follow a Maxwellian distribution in energy, or 
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where a is the magnitude, 𝐾B is Boltzmann constant, and 𝐾B𝑇 is the most probable kinetic en-
ergy, which is equal to 0.025 eV, corresponding to absolute temperature 𝑇 of 293 K. 
Figure 2.2. Geometry of a general-purpose proton treatment head and water phantom. Adapted 
from Perez-Andujar et al. (2013). 
The distribution of 1 𝐸n





′)   [1 − cnorm(𝐸n, 𝜇3,𝜎3
′)]
(16) 
where 𝑏 represents the magnitude and the cumulative normal functions restrict contributions to 
the epithermal energy interval, with smooth transitions to neighboring regimes. The parameters 
13 
for cumulative normal functions restrict 1 𝐸n
⁄  neutron contribution to other energy regimes, spe-
cifically below 10−7 MeV and above 1 MeV. These parameters were empirically obtained.
Evaporation neutrons were modeled using a normalized gaussian, or 









where 𝑐 is the magnitude, ?̅?3 is the mean energy of evaporation peak and 𝑠 is the peak width pa-
rameter. Equation (15), (16) and (17) represent isotropic emission as discussed earlier. 
The cascade neutrons were modeled empirically using three gaussian peaks according to 




























where 𝛿, 𝑒, and  𝑓(𝜃) are peak magnitudes, 𝑞, 𝑤, and 𝑟 denote the peak widths and ?̅?4,low,
?̅?4,mid, and ?̅?4,high(𝐸p) are the mean energies, respectively. Physically the peaks correspond to 
neutrons generated through proton and single nucleon interactions, proton and multiple nucleon 
interactions and pre-equilibrium emission. 
The mean energy of the highest energy gaussian of the cascade neutron regime, 
?̅?4,high(𝐸p), has linear dependence on incident proton energy, as was expected from considera-
tions of relativistic head on collision of nucleons, or 
?̅?4,high(𝐸p) = 𝛼p𝐸p − 𝛽p (19) 
where 𝛼𝑝 and 𝛽𝑝 are empirical fit parameters. Similarly, ?̅?4,med was proportional to ?̅?4,high(𝐸p) 
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?̅?4,med =  𝛾 ?̅?4,high(𝐸p) (20) 
where 𝛾 is empirical fit parameter. All of the neutrons in the “cascade regime” were modeled 
with isotropic emission, except those from nucleon-nucleon collisions (i.e., the last term in Equa-
tion (18)), which takes into account the directional dependence of emission of the highest energy 
neutrons that are preferentially emitted in the forward cone, or  
𝑓(𝜃) = 𝛼f − 𝛽f 𝜃 (21) 
where 𝜃 is the angle between the central axis and a ray from the source to the calculation point 
𝑝(𝑥, 𝑦, 𝑧) (Figure 2.2), and 𝛼f and 𝛽f are empirical fit parameters. 
2.3.2 Neutron Spectral Fluence Data 
We used neutron spectral fluence and energy deposition data from simulations of the pas-
sive scattering system (Perez-Andujar et al. 2013). These simulations used the Monte Carlo Pro-
ton Radiotherapy Treatment Planning (MCPRTP) system (Newhauser et al. 2007), which lever-
ages the Monte Carlo N-Particle eXtended (MCNPX) Radiation Transport Code (Hendricks et 
al. 2006). MCNPX is commonly used for simulating neutron exposures and previously has been 
extensively benchmarked against measurements (Tayama et al. 2002, Fontenot et al. 2005, 
Herault et al. 2005, Tayama et al. 2006, Koch et al. 2008, Farah et al. 2014). Simulations were 
performed for an 18 × 18 cm2 field prior to the final collimator, which was fully closed. Neutron 
absorbed dose and neutron spectral fluence were tallied in simulations of pristine proton beams 
with mean energies at the nozzle entrance of 100, 120, 140, 160, 180, 200, 225, and 250 MeV. 
Neutron spectral fluence was tallied in equally spaced logarithmic neutron energy bins (40 bins 
per decade). A water phantom of size 30 ×  180 ×  44  cm3 was used with 100 spherical tally
volumes, each 1cm in diameter.  The tally volumes were located along the lines parallel to the 
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beam axis at 0 cm, 12 cm, 40 cm, and 80 cm off-axis, as well as one-line perpendicular to the 
beam axis at the depth of isocenter in the phantom (22 cm) (see Figure 2.2).    
2.3.3 Training of Analytical Model of Neutron Spectral Fluence 
We trained our neutron spectral fluence model for the general-purpose beamline at 
MDACC, using data from all the tally volumes (Figure 2.2) with proton beam energies of 120 
MeV, 140 MeV, 160 MeV, 180 MeV, 200 MeV, 225 MeV and 250 MeV. The 100-MeV spectral 
fluence data was not available. The spectral fluence model was fit simultaneously to all 672 sim-
ulated neutron spectra using the Marquardt-Levenberg algorithm of (GNUPLOT Version 5.2) 
(Williams et al. (2017)) and minimizing weighted sum squared error (WSSR) until a preset crite-
rion (10-5, which was the default value) was met. Simultaneously fitting all spectra allowed direct 
and global estimation of all fitting parameters, including parameters that have no explicit de-
pendence on proton energy or position in the phantom. All of the empirical fitting parameters 
were selected by minimizing the local relative differences in spectral fluence. The fitting process 
took into account the statistical uncertainties in the spectral fluence from Monte Carlo simula-
tions via WSSR. Additionally, the mean energy of the evaporation peak, ?̅?3, and low-energy cas-
cade peak, ?̅?4,low, were constrained to be greater than 0.9 MeV based on measured spectra 
(Trinkl et al. 2017). Finally, the exponent 𝜏 of the neutron fluence-divergence factor was re-
stricted to be less than 2, which is the maximum physically possible value corresponding to in-
verse-square divergence from a point source of radiation. 
2.3.4 Model Validation 
To validate the neutron spectral fluence model (Eq. (10)) we used three separate ap-
proaches. First, we integrated it according to   
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where ϕj(𝐸n) is the differential fluence in the j
th bin of the neutron spectral fluence and Δ𝐸j is
the width of that bin. 
In the second approach, we compared values of the neutron-fluence-weighted mean neu-
tron energy, ?̅?n, from MC simulations and analytical model calculations. The mean was calcu-
lated using 
?̅?n =  
∫ ϕ(𝐸n)  𝐸n 𝑑𝐸n
𝐸max
0




∑ ϕj(𝐸n)j 𝐸n Δ𝐸j 
∑ 𝜙j(𝐸n)j  Δ𝐸j
(23) 
where ϕj(𝐸n) is the differential fluence in the j
th bin of the neutron spectral fluence and Δ𝐸j is
the width of that neutron energy bin. 
In the third approach we calculated the neutron-fluence-weighted mean neutron kerma 
coefficient as 
?̅?ϕ(𝐸n) =  
∫ ϕ(𝐸n)  𝑘ϕ(𝐸n) d𝐸n
𝐸max
0




∑ ϕj(𝐸n)j  𝑘ϕ(𝐸n) Δ𝐸j
∑ 𝜙j(𝐸n)j  Δ𝐸j
(24) 
where ϕj(𝐸n) is the differential fluence in the j
th bin of the neutron spectral fluence and Δ𝐸j is
the width of that energy bin. To cross check the calculation of ?̅?ϕ(𝐸n) in Equation (24), we also
calculated it as 
?̅?ϕ(𝐸n) = 𝑘ϕ(?̅?n) (25) 
where ?̅?n was taken from Equation (23). 
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2.4 Kerma Calculation 
Using the kerma coefficient model and neutron spectral fluence model, kerma at a point 
was calculated using Equation (5). To cross check this result, we calculated kerma as 
𝐾 = Φ  𝑘ϕ(?̅?n) (26) 
where Φ is the fluence from Equation (22).  
2.5 Absorbed-Dose Calculation 
2.5.1 Kerma-to-Absorbed-Dose Conversion Factor 
Kerma and absorbed dose are two different physical quantities that are related but not nu-
merically equal, except where CPE exists. Thus, in general a conversion factor, 𝐹𝐾→𝐷 , is needed 
to transform kerma to absorbed dose. This conversion factor is given by  




           =  
𝐷MC




 =  
𝐷MC














If we assume equivalence of  𝑘ϕ
ICRU(𝐸n) and 𝑘ϕ
MC(𝐸n), the second term in equation becomes
equal to 1, yielding 
𝐹𝐾→𝐷 =
𝐷MC





where, 𝐷MC is dose from MC simulations.  
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2.5.2 Surface Correction Factor 
To account for interface effects near the surface of the phantom, we used an empirical 
shallow-depth correction factor given by, 
𝐹S = {
𝛼s(1 − 𝑒
−𝜇s 𝑧)  𝑥 ≤ 40 cm
1 𝑥 > 40 cm
(29) 
where 𝛼s, 𝜇s are fit parameters, x is off axis distance and z is depth in water. 
Finally, with inclusion of kerma-to-absorbed-dose conversion factor and surface-correc-
tion factor the absorbed dose is given by 
𝐷AM = 𝐹S  𝐹𝐾→𝐷  𝐾𝐴𝑀 (30) 
where 𝐾AM is kerma calculated using Equation (6). 
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Chapter 3. Results 
3.1 Empirical Model of Kerma Coefficient 
Table 3.1 lists the parameters for the analytical model for neutron kerma coefficients (Eq. 
9) for the materials listed in table C.3 in ICRU Report 63 (2000). The model was in excellent
agreement over the energy interval from 2.53 × 10−8 MeV to 150 MeV for water with average
1.20% relative difference. Figure 3.1 shows agreement between our model and evaluated ICRU 
data for neutron kerma coefficients in water. Further this model was in good agreement for other 
materials with average relative difference within 6% as illustrated in Table 3.2.  















A150 Plastic 2.697 × 10−5 59.25 3.333 1.754 2.754 7.622 
Water 4.645 × 10−7 43.30 2.705 1.571 2.377 7.402 
Muscle 2.731 × 10−5 46.49 2.911 1.627 2.491 7.140 
Bone 2.112 × 10−5 82.57 4.285 1.943 2.706 5.738 
TE − Meth 2.412 × 10−5 53.71 3.114 1.690 2.628 7.387 
TE − Prop 2.395 × 10−5 53.98 3.163 1.685 2.641 7.307 
Note: All significant digits provided should be used to calculate kerma coefficient values and 
threshold energy, 𝐸n,Thresh, of 23 MeV was used for all materials. 
Higher energy neutrons contributes the majority of kerma because of larger fluence and 
kerma coefficient values at higher energies. Since the ICRU tabulated data ranges from thermal 
energies up to 150 MeV, extrapolation was used beyond that energy as shown in Figure 3.1.  
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Figure 3.1. Neutron kerma coefficient 𝑘ϕ(𝐸n) versus neutron energy, 𝐸n, in water. Data are from
ICRU Report 63 (points) and the analytical model [Eq. (9)] (line). The absolute difference be-
tween kerma coefficient, ∆𝑘ϕ(𝐸n), are also plotted (right ordinate).
Table 3.2. Average and maximum relative difference in neutron kerma coefficients between data 
from ICRU Report 63 and the analytical model over energy range from 2.53 × 10−8 MeV  to







A150 Plastic 5.110 104.32 
Water 1.200 35.76 
Muscle 5.110 53.42 
TE − Methane 5.800 81.67 
TE − Propane 3.630 84.05 
Bone 2.400 93.61 
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3.2 Analytical Model of Neutron Spectral Fluence 
3.2.1 Parameter Values 
Table 3.3 lists the parameters of the analytical model that govern the  ϕi(𝐸n) in Equa-
tions (15) to (18), 𝐴𝐹i in Equation (13) and 𝑂𝐴𝐹i in Equation (14). The parameters governing en-
ergy scaling (Eq. 11) are in Table 3.4. These parameters were used to evaluate Equation (10) to 
calculate neutron spectral fluences. As expected, the effective gaussian width parameters of 
OAF’s for the low energy neutron regimes, epithermal and thermal, are large corresponding to 
isotropic distribution whereas it is small for cascade neutrons because of their emission in the 
forward direction. The exponent, 𝜏, governing divergence of neutron fluence was found to be 
1.013. Figure 3.2 plots spectral fluence at isocenter, demonstrating how it varies with proton 
beam energy.  
Figure 3.2. Selected examples of neutron spectral fluence at isocenter produced by 120 to 250-
MeV proton beams. These were calculated using the analytical model [Eq. (10)]. 
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Table 3.3. Parameters governing neutron spectral fluence, ϕi(𝐸n) [Eq. (15-18)], neutron attenua-
tion factor, 𝐴𝐹i [Eq. (13)] and off-axis factor, 𝑂𝐴𝐹i  [Eq. (14)] 
Neutron Energy Regime Parameter Value Units 
Thermal 
𝑎 2.04 × 1010 cm−2 MeV−1
𝛼1 0.036 cm
−1








′ 3.3 × 10−8 MeV 
𝜇3 1.0 MeV 
𝜎3
′ 0.5 MeV 
𝛼2 0.033 cm
−1
𝜎2 86.51 cm 
Evaporation 𝑐 1.1 × 10−7 cm−2 MeV
𝑠 2.81 MeV 
?̅?3 0.9 MeV 
𝛼3 0.013 cm
−1
𝜎3 16.11 cm 
Cascade 𝑑 1.88 × 10−6 cm−2 MeV
𝑒 4.71 × 10−7 cm−2 MeV
?̅?4,low 1.01 MeV 
𝛾 0.78 − 
𝑞 18.26 MeV 
𝑤 18.78 MeV 
𝑟 29.41 MeV 
𝛼f 1.67 × 10
−6 cm−2 MeV
𝛽f 1.23 × 10
−8 cm−2 MeV
𝛼p 0.93 − 
𝛽p 82.70 MeV 
𝛼4 0.013 cm
−1
𝜎4 44.42 cm 
Table 3.4. Parameters for modeling dependence of neutron spectral fluence on proton beam en-
ergy, as defined in Equation (11). 
Parameter Value Units 
αE 6704.46 − 
ξ 2.53 −
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Figure 3.3 and 3.4 are illustrative examples of how well the analytical model reproduced 
neutron spectral fluence data from MC simulations. 
Figure 3.3. Selected examples of neutron spectral fluence at 22-cm and 40-cm water depth along 
central axis produced by 180-MeV proton beams. Green lines with error bars represent data from 




Figure 3.4. Selected examples of neutron spectral fluence at 22-cm and 40-cm water depth along 
80 cm off-axis distance produced by 180-MeV proton beams. Green lines with error bars repre-
sent data from Monte Carlo simulations and purple lines are from the analytical model.  
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Figure 3.4 shows how well our model agrees with MC data at 22 cm (isocentric depth) 
and 40 cm along central axis. Figure 3.5 illustrates the agreement between analytical model and 
Monte Carlo data in predicting kerma contribution. As expected, kerma is predominated by from 
high energy cascade neutrons.  
Figure 3.5. Predication of kerma contribution from Monte Carlo (red) and analytical model 
(blue) versus neutron energy at 25-cm water depth along central axis for 180-MeV proton beam. 
3.2.1 Comparison of Neutron Fluence from Monte Carlo Simulation and Analytical Model 
Figure 3.6 plots predictions of fluence from Monte Carlo and analytical models for 120-
MeV, 180-MeV and 250-MeV proton beams in water. Figure 3.6 (a) shows the fluence variation 
with water depth along central axis, while Figure 3.6 (b) shows the corresponding result at 12 cm 
off-axis distance. Both figures demonstrate generally good agreement beyond approximately 7-
cm water depth. Figure 3.7 plots lateral distribution of fluence at 22-cm water depth.  
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. 
Figure 3.7. Selected example predictions from Monte Carlo (points) and analytical model (lines) 
of neutron fluence versus off-axis position at 22-cm depth in water for 120-MeV, 180-MeV and 
250-MeV proton beams.
Figure 3.6. Selected example predictions from Monte Carlo (points) and analytical model (lines) of 
neutron fluence Φ versus depth z in water at (a) central axis, (b) 12-cm off-axis distance for 120-
MeV, 180-MeV and 250-MeV proton beams. 
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Since our analytical model of neutron spectral fluence doesn’t account the loss of neu-
trons from the surface of the water phantom, we observed the largest disagreement at shallow 
depths, close to the surface, where we overestimated the fluence. The analytical model prediction 
of fluence is in reasonable agreement with MC data along the profile at 22 cm depth. The largest 
differences were observed at 40-cm off-axis distance in this case. 
3.2.3 Fluence-Weighted Average Neutron Energy and Average Neutron Kerma Coefficient 
Table 3.5 lists the neutron fluence-weighted average energy and neutron fluence-
weighted average kerma coefficient values for selected locations for a 180-MeV proton beam, 
including relative differences. There is relatively good agreement between MC calculated values 
and analytical model except at shallower depths and far off-axis locations. The agreement was 
observed to improve with depth.  
Table 3.5. Fluence-weighted average neutron energy, ?̅?n,  [Eq. (23)] and fluence-weighted aver-
age kerma coefficient, ?̅?ϕ, [Eq. (24)] including relative difference for 180-MeV proton beams 
from analytical model (AM) calculations and Monte Carlo simulations (MC) at selected loca-
tions in a water phantom. 
 Location 
(x, y, z) 
















(0,0,13) 9.68 7.97 21.45 1.62 1.50 8.00 
(0,0,22) 21.43 18.81 13.92 3.22 2.94 9.52 
(0,0,43) 38.73 46.15 −16.07 5.54 6.31 −12.20
(12,0,13) 8.38 6.77 23.78 1.34 1.38 −2.89
(12,0,22) 18.74 17.25 8.63 2.83 2.80 1.07 
(12,0,43) 34.16 44.53 −23.28 4.95 6.19 −20.03
(40,0,13) 8.13 4.65 74.83 1.24 1.03 20.38 
(40,0,22) 21.30 14.10 51.06 3.16 2.50 26.45 
(40,0,43) 36.31 42.94 −15.44 5.29 6.11 −13.42
(80,0,13) 2.49 5.7 −56.31 0.41 1.12 −63.39
(80,0,22) 20.97 16.26 28.96 3.21 2.81 14.23 
(80,0,43) 40.27 36.49 10.35 5.99 5.48 9.31 
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Table 3.6 lists the average and maximum relative differences between the ?̅?n values cal-
culated with Monte Carlo simulations and those predicted by the analytical model. Consistent 
with our findings from fluence calculations, the largest differences are associated with tallies at 
shallow water depths and large off-axis distance.  
Figure 3.8 plots the variation of fluence-weighted mean neutron energy with off-axis dis-
tance and depth for 120-MeV, 180-MeV, and 250-MeV proton beams.  Average neutron energy 
increases with depth and reaches a maximum value and then decreases gradually. The average 
neutron energy decreases gradually with off axis distance and then increases. Further, average 
neutron energy also increases monotonically with incident proton energy. 
Table 3.6. Average relative difference, ∆?̅?n
̅̅ ̅̅ ̅, and maximum relative difference,









 ∆?̅?n |Max 
250 16 −99 (80,0,1) 
225 19 −98 (80,0,1) 
200 20 −99 (80,0,1) 
180 21 −94 (80,0,1) 
160 23 −99 (80,0,1) 
140 23 −99 (80,0,1) 
120 18 −160 (80,0,43) 
Table 3.7 lists the average and maximum relative differences between the ?̅?ϕ values cal-
culated with Monte Carlo simulations and the analytical model for all the energies considered. 
Consistent with our findings from fluence calculations and average energy comparison, the larg-
est differences were observed at shallow water depths and at large off-axis distance.  
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Figure 3.8. Variation of average neutron energy with off-axis distance and depth for 120-MeV, 
180-MeV and 250-Mev proton beam.
Table 3.7. Average relative difference, ∆?̅?ϕ
̅̅ ̅̅ ̅, and maximum relative difference,
∆?̅?ϕ|Max, between  ?̅?ϕ values calculated by Monte Carlo method [Eq. (24)] and analytical model 








 Location of 
∆?̅?ϕ |Max 
250 29 −150 (80,0,1) 
225 29 −98 (80,0,1) 
200 28 −97 (80,0,1) 
180 25 98 (80,0,1) 
160 15 97 (80,0,1) 
140 19 98 (80,0,1) 
120 11 −150 (80,0,43) 
3.3 Neutron Kerma Calculation 
Table 3.8 lists the neutron kerma values calculated at select locations using both MC data 
[Eq. (26)] and the analytical model [Eq. (5)] for 120-MeV and 250-MeV proton beams. These 
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exhibit reasonably good agreement except at shallow depths and large off-axis distance. Figure 
3.9 plots the variation of kerma calculated based on Monte Carlo simulation and our analytical 
model at 22-cm water depth for 120-MeV, 180-MeV and 250-MeV proton beams. Consistent 
with previous results we see that our model predicts kerma with relatively good accuracy near 
the central axis but overpredicts the fluence at 40-cm off-axis distance. 
Table 3.8. Select examples of neutron kerma and relative difference for 120-MeV and 250-MeV 




(cm, cm, cm) 













(0,0,22) 9.37 × 10−16 9.22 × 10−16 1.6 8.15 × 10−17 7.34 × 10−17 11 
(12,0,22) 8.77 × 10−16 7.30 × 10−16 20 7.37 × 10−17 5.71 × 10−17 29 
(40,0,22) 5.35 × 10−16 2.11 × 10−16 128 3.85 × 10−17 1.27 × 10−17 203 
(80,0,22) 1.15 × 10−16 6.09 × 10−17 69 8.35 × 10−18 4.11 × 10−18 103 
Figure 3.9. Predicted kerma, K, from Monte Carlo (points) and analytical model (lines) of kerma 
versus off-axis position, x, at 22-cm depth in a water for 120-MeV, 180-MeV and 250-MeV pro-
ton beam. 
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3.4 Absorbed-Dose Calculation 
3.4.1 Kerma-to-Absorbed Dose Conversion Factor and Surface Correction Factor 
Using Eq. (28), we calculated kerma-to-absorbed-dose conversion factor, 𝐹𝐾→𝐷  at all the 
tally locations. Figure 3.10 plots variation of absorbed dose reported by MC and kerma calcu-
lated using MC data for 180-MeV proton beam with off-axis distance whereas Figure 3.11 plots 
𝐹𝐾→𝐷  versus off-axis distance for the same case. Absorbed dose along the profile was found to 
be slightly greater than kerma for most locations. The fluctuations in kerma-to-absorbed-dose 
conversion factors were averaged and a value of 1.18 was used as conversion factor.  
Figure 3.10. Comparison of absorbed-dose, D, and kerma, K, calculated using MC data versus 
off-axis distance xfrom a 180-MeV proton beam at 22-cm depth in a water phantom. 
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Figure 3.11. Kerma-to-absorbed dose conversion factor, 𝐹𝐾→𝐷 , versus off-axis distance for 180-
MeV proton beam at 22-cm depth.  
The values of the parameters governing the shallow depth correction (Eq. 29) 𝛼s and 
𝜇swere empirically found to be 0.72 and 0.2781 cm
−1 respectively.
3.4.2 Corrected Absorbed Dose Calculation 
We utilized the kerma-to-absorbed-dose conversion factor and surface correction factor 
to calculate absorbed dose in water using Equation (30). The absorbed dose from MC simulation 
and our model are shown in Figure 3.12, revealing relatively good agreement. Consistent with 
our fluence and kerma predictions, our model predicts dose with relatively good accuracy along 
central axis and a slight overprediction of absorbed dose near 40 cm off-axis distance.  
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Figure 3.12. Predictions of absorbed dose, D, from analytical model (lines) and Monte Carlo cal-
culation (points) versus off-axis distance, x, in water for 120-MeV, 180-MeV and 250-MeV pro-
ton beams at 22-cm depth. 
Figure 3.13 plots the absorbed dose versus depth along central axis from the MC simula-
tions and analytical model for 120-MeV, 180-MeV and 250-MeV proton beams. The figure re-
veals good agreement between the MC and analytical model predictions. Table 3.9 lists the aver-
age relative difference, ∆?̅? , and the maximum relative difference, ∆?̅? |Max, between values. The 
average relative difference at all the locations in phantom for all energies was about 50%. The 
maximum relative differences were observed mostly at 80-cm off-axis distances and at deeper 




Figure 3.13.  Prediction of absorbed dose, D, from analytical model (lines) and Monte Carlo cal-
culation (points) versus depth in water, z, for 120-MeV, 180-MeV and 250-MeV proton beams. 
 
Table 3.9. Average relative difference, ∆𝐷̅̅ ̅̅  , and maximum relative difference, ∆𝐷 |Max, between 
absorbed-dose values calculated by Monte Carlo method and the analytical model considering all 









    ∆𝐷 |Max  
(x, y, z) cm 
250 52 217 (80,0,40) 
225 50 173 (80,0,37) 
200 43 187 (80,0,27) 
180 52 269 (80,0,43) 
160 47 264 (80,0,28) 
140 54 263 (80,0,37) 
120 92 374 (80,0,27) 
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Chapter 4. Discussion 
An analytical model was developed to calculate the neutron spectral fluence, kerma, and 
absorbed dose in a water-box phantom for passively scattered proton therapy beams of 120 MeV 
to 250 MeV. The model calculates neutron spectral fluence, then applies neutron kerma coeffi-
cients to obtain kerma, and finally applies a kerma-to-absorbed dose conversion factor and a sur-
face correction factor. Evidently, it is possible to predict absorbed dose due to stray neutrons 
with an analytical approach within reasonable accuracy. Average relative difference observed in 
case of neutron spectral fluence, neutron kerma coefficient and absorbed dose were approxi-
mately 23%, 6% and 50% respectively. 
This model, with some refinements, appears potentially suitable for integration in treat-
ment planning system. Because the model is physics-based, we believe it is generally applicable, 
i.e., can be utilized for a variety of treatment systems. The fluence model allows calculation of 
kerma and absorbed dose, which are measurable quantities, facilitating validation and calibra-
tion. This approach also helps us separately calculate the physical and the biological aspects of 
neutron exposures, i.e., it provides a method to calculate absorbed dose, rather than equivalent 
dose which takes into account neutron quality, which is challenging in radiation therapy expo-
sures. For these reasons, our model could enable risk calculations in prospective and retrospec-
tive cases, providing a potentially powerful tool for designing and conducting epidemiology 
studies and clinical trials. 
The results from this work are generally consistent with the findings from previous stud-
ies. Perez-Andujar et al. (2013) found that analytical models of neutron exposure required 49 pa-
rameters to predict equivalent dose. Schneider et al. (2015) subsequently improved the model 
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from Perez-Andujar et al. (2013) reducing the required number of parameters to 22. In compari-
son, our analytical model with just 40 parameters calculates numerous quantities with reasonable 
accuracy. Thus, our model is similarly parsimonious but with the capability to predict more 
quantities (Φ(𝐸n), Φn, 𝐾, D), albeit at lower accuracy than that reported by Perez-Andujar et al.
(2013). Recently, Dommert et al. (2017) reported a neutron spectral fluence model but with less 
resolution of structure above 1 MeV. The approach of Dommert et al. (2017) requires 11 param-
eters per spectral fluence whereas our model requires 18 parameters per spectral fluence but has 
higher resolution above 1 MeV. The reported model from Dommert et. al. (2017) did not explic-
itly account for proton beam energy, neutron source position, fluence divergence and attenuation. 
In contrast, our neutron spectral fluence model uses 30 parameters and predicts spectra at all the 
locations in a water phantom for wide range of energies. Additional, we explicitly modeled 
source position, attenuation, source distribution.  
This project has several strengths. We used a vast amount of high quality radiometric 
data to train our model. Further, our model uses relatively simple physics-based theories, that 
provide good explanatory power. Additionally, we modeled the intermediate quantities neutron 
spectral fluence and kerma rather than dose equivalent. ϕ(𝐸n) and 𝐷 can be directly confirmed
by radiation measurements, e.g., in the reference field at a standards laboratory. Being able to 
calculate  ϕ(𝐸p, 𝑥, 𝑦, 𝑧) gives valuable information about the radiation quality (e.g., mean neu-
tron energy) and allows for material dependence in kerma and absorbed-dose calculations.   
A limitation of this work is that physics of radiation transport near the surface of phantom 
is more complex than our spectral fluence model takes into account, as evidenced by relatively 
poor agreement in some surface regions. Another limitation of the study is that it only uses MC 
simulated data, i.e., no measurements were used. This is not a major limitation because the MC 
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code was previously benchmarked extensively in the literature. Additionally, we used only a wa-
ter-box phantom data and thus we have not tested its capabilities in anatomic phantoms. This is 
not a serious limitation because the goal of this project is to investigate the feasibility of model-
ing the underlying transport physics in a simple phantom.  
Future work should include study of the physics of neutron transport to improve accuracy 
in absorbed dose, especially near the phantom surfaces, extend the energy interval to lower pro-
ton beam energies (~ 50 MeV) for ocular treatments. Additional work should focus on imple-
mentation in treatment planning system and validation against measurements. Finally, computa-
tional speed should be investigated because of the large number of calculation points needed for 
whole-body dose assessments. 
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Chapter 5. Conclusion 
In this work, we developed a physics based analytical model of neutron spectral fluence 
and an empirical model of neutron kerma coefficients. We combined these to calculate kerma 
and absorbed dose from stray neutrons. An empirical model of neutron kerma coefficient re-
vealed good agreement with evaluated data from the literature upto 150 MeV. The analytical 
model for neutron spectral fluence also revealed relatively good agreement with that from MC 
data. A study of kerma-to-absorbed-dose conversion factor was also performed which suggested 
it can be approximated as a constant.  
The results suggest that it is feasible to use the neutron-fluence-based approach to predict 
absorbed dose to water from stray neutrons with relatively good accuracy except at shallower 
depths and far off-axis locations. The results of this work suggest that, with further development 
and testing, it appears potentially conceivable to perform routine absorbed dose calculation of 
stray neutron exposure to patients who receive proton beam therapy. A potentially important ad-
vantage of this fluence-based approach is that it provides us the ability to take material depend-
ence into account and facilitates characterization of radiation quality of the neutron fields.  
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